It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Retention is a key element in HIV prevention programs. In Sub-Saharan Africa most data on retention come from HIV clinical trials or people living with HIV attending HIV treatment and control programs. Data from observational cohorts are less frequent. Retention at 6-/12-month follow-up and its predictors were analyzed in OKAPI prospective cohort. From April 2016 to April 2018, 797 participants aged 15–59 years attending HIV Voluntary Counseling and Testing in Kinshasa were interviewed about HIV-related knowledge and behaviors at baseline and at 6- and 12-month follow-ups. Retention rates were 57% and 27% at 6- and 12-month follow up; 22% of participants attended both visits. Retention at 6-month was significantly associated with 12-month retention. Retention was associated with low economic status, being studying, daily/weekly Internet access, previous HIV tests and aiming to share HIV test with partner. Contrarily, perceiving a good health, living far from an antiretroviral center, daily/weekly alcohol consumption and perceiving frequent HIV information were inversely associated with retention. In conclusion, a high attrition was found among people attending HIV testing participating in a prospective cohort in Kinshasa. Considering the low retention rates and the predictors found in this study, more HIV cohort studies in Kinshasa need to be evaluated to identify local factors and strategies that could improve retention if needed.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of Navarra, Department of Preventive Medicine and Public Health, Pamplona, Spain (GRID:grid.5924.a) (ISNI:0000000419370271); IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain (GRID:grid.508840.1) (ISNI:0000 0004 7662 6114); University of Navarra, Institute for Culture and Society, Pamplona, Spain (GRID:grid.5924.a) (ISNI:0000000419370271)
2 Université de Mwene-Ditu, Faculté de Médecine, Mwene-Ditu, Democratic Republic of the Congo (GRID:grid.5924.a)
3 Monkole Hospital/CEFA, Kinshasa, Democratic Republic of the Congo (GRID:grid.5924.a)
4 Clínica Universidad de Navarra, Microbiology Department, Pamplona, Spain (GRID:grid.411730.0) (ISNI:0000 0001 2191 685X)
5 IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain (GRID:grid.508840.1) (ISNI:0000 0004 7662 6114); University of Navarra, Institute for Culture and Society, Pamplona, Spain (GRID:grid.5924.a) (ISNI:0000000419370271); University of Navarra, School of Education and Psychology, Pamplona, Spain (GRID:grid.5924.a) (ISNI:0000000419370271)